Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding

Study Overview
=================
Brief Summary
-----------------
In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Uroflowmetry, Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form were applied to all participants at baseline and at week 6.

Detailed Description
-----------------
In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. This experimental study was conducted with patients who applied to UroKlinik in Istanbul between March 2021 and June 2023 and were diagnosed with dysfunctional voiding. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form and Uroflowmetry test were applied to all participants before and at week 6.

Official Title
-----------------
The Effect of Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding : A Randomized Clinical Trial

Conditions
-----------------
Dysfunctional Voiding

Intervention / Treatment
-----------------
* Other: Exercise
* Other: Standard therapy


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Having been diagnosed with dysfunctional voiding, Being between the ages of 18-75, Not having a neurogenic bladder Not having a urinary tract infection Not having an obstacle to exercise, Accepting and signing the Approval Form, Not having undergone surgery in the last 6 months, Exclusion Criteria: Not being cooperative Not being able to participate in the treatment, The use of drugs that will affect urination

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 75 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Dynamic Neuromuscular Stabilisation Exercise<br>The participants performed DNS exercises addition to standard therapy | Other: Exercise<br>* Dynamic Neuromuscular Stabilisation Exercise<br>Other: Standard therapy<br>* Patient education, massage, diaphragmatic breathing, kegel exercise<br>|
| Other: Standard therapy<br>Patient education, massage, diaphragmatic breathing, kegel exercise | Other: Standard therapy<br>* Patient education, massage, diaphragmatic breathing, kegel exercise<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Uroflowmetry - Maximum flow rate (Qmax) | Uroflowmetry gives information about urine flow rate and voiding pattern. *Qmax (mL/s): Qmax is the fastest stream measured in mL/s. | at the baseline and at week 6. | 
| Uroflowmetry - Average flow rate (Qave) | Uroflowmetry gives information about urine flow rate and voiding pattern. *Qave (mL/s): Qave is the average stream measured in mL/s. | at the baseline and at week 6. | 
| Uroflowmetry - Corrected maximum flow rate (cQmax) | Uroflowmetry gives information about urine flow rate and voiding pattern. *cQmax (mL/s/√ mL): cQmax is the precise assessment of fastest stream, especially at high volumes. Is it estimated Qmax/√ VV. | at the baseline and at week 6. | 
| Uroflowmetry - Flow time (FT) | Uroflowmetry gives information about urine flow rate and voiding pattern. *FT (s): FT is the time over which measurable flow actually occurs. | at the baseline and at week 6. | 
| Uroflowmetry - Voiding volume (VV) | Uroflowmetry gives information about urine flow rate and voiding pattern. *VV (ml): VV indicates the amount of voiding. | at the baseline and at week 6. | 
| Uroflowmetry - Residual urine (RU) | Uroflowmetry gives information about urine flow rate and voiding pattern. *RU (ml): RU is the amount of urine that is left behind in the bladder after you are done urinating. | at the baseline and at week 6. | 
| Dysfunctional Voiding and Incontinence Symptom Score | It gives information about voiding and incontinence symptoms. The questionnaire contains fourteen questions about symptoms and quality of life. The total score ranges from 0 to 35 and a score above 8.5 indicates abnormalities. | at the baseline and at week 6. | 
| Short Form 36 | It gives information about health related quality of life. The total score of the scale ranges from 0 to 100, and a high score indicates a high quality of life. | at the baseline and at week 6. | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
dysfunctional voiding, dynamic neuromuscular stabilization exercise